Sarah Caroline Gomes de Lima
Overview
Explore the profile of Sarah Caroline Gomes de Lima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biggi A, Silvestre R, Tirapelle M, Azevedo J, Mogollon Garcia H, Henrique Dos Santos M, et al.
Cytotherapy
. 2024 Jul;
26(11):1320-1330.
PMID: 38970613
Chimeric antigen receptor (CAR) engineering of natural killer (NK) cells has shown promising results in early-phase clinical studies. However, advancing CAR-NK cell therapeutic efficacy is imperative. In this study, we...
2.
Machado C, da Silva E, Ferreira W, DE Pinho Pessoa F, de Quadros A, Fantacini D, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067214
Detection of t(9;22), and consequent fusion, is still a marker of worse prognosis for acute lymphoblastic leukemia (ALL), with resistance to tyrosine-kinase inhibitor therapy being a major obstacle in the...
3.
de Lima S, Fantacini D, Furtado I, Rossetti R, Silveira R, Covas D, et al.
Adv Exp Med Biol
. 2023 Jul;
1429:85-110.
PMID: 37486518
Our current genetic engineering capacity through synthetic biology and genome editing is the foundation of a revolution in biomedical science: the use of genetically programmed cells as therapeutics. The prime...
4.
Barbosa H, Piva H, Matsuo F, de Lima S, de Souza L, Osako M, et al.
Int J Biol Macromol
. 2023 May;
242(Pt 1):124647.
PMID: 37146851
Glioblastoma (GBM) is the most common brain cancer characterized by aggressive and infiltrated tumors. For this, hybrid biopolymer-lipid nanoparticles coated with biopolymers such as chitosan and lipidic nanocarriers (LN) loaded...
5.
de Lima S, Fantacini D, Batista L, Silveira R, Furtado I, Rossetti R, et al.
Crit Rev Immunol
. 2021 Apr;
41(1):41-67.
PMID: 33822524
The field of cell therapy is leading a paradigm shift in drug development. The recent convergence of several fields, including immunology, genetics, and synthetic biology, now allows for the introduction...